Oncotype DX score in hormone receptor-positive/HER2-positive breast cancer: A SEER analysis.

e12044Background: The recurrence score Oncotype DX (RS) predicts the need for adjuvant chemotherapy in hormone receptor positive (HR+) early stage breast cancer (BC). However, it has not been valid...